Heimberg M, Olubadewo JO, Wilcox HG: Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev. 1985, 6: 590-607.
Pucci E, Chiovato L, Pinchera A: Thyroid and lipid metabolism. Int J Obesity Rel Metab Dis. 2000, 24: S109-S112. 10.1038/sj/ijo/0801292.
Diekman MJ, Anghelescu N, Endert E, Bakker O, Wiersinga WM: Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J Clin Endocrinol Metab. 2000, 85: 1857-1862. 10.1210/jc.85.5.1857.
Ukkola O, Santaniem M: Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med. 2002, 80: 696-702. 10.1007/s00109-002-0378-7.
Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J: Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett. 2003, 545: 103-104. 10.1016/S0014-5793(03)00568-4.
Valsamakis G, Chetty R, McTerman PG, Al-Daghri NM, Barnett AH, Kumar S: Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab. 2003, 5: 131-135. 10.1046/j.1463-1326.2003.00254.x.
Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism. 2003, 52: 1274-1278. 10.1016/S0026-0495(03)00195-1.
Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H: Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003, 361: 226-228. 10.1016/S0140-6736(03)12255-6.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002, 8: 1288-1295. 10.1038/nm788.
Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002, 13: 51-59. 10.1097/00041433-200202000-00008.
Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Ravussin E, Weyer C: Plasma adiponectin levels are not associated with fat oxidation in humans. Obes Res. 2002, 10: 1016-1020.
Cianflone K, Xia Z, Chen LY: Critical review of Acylation Stimulating Protein physiology in humans and rodents. Biochim Biophys Acta. 2003, 1609: 127-143.
Cianflone K, Sniderman AD, Walsh MJ, Vu H, Gagnon J, Rodriguez MA: Purification and characterization of acylation stimulating protein. J Biol Chem. 1989, 264: 426-430.
Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B: The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest. 1993, 92: 1543-1547.
Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Volta U: Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiology. 1998, 53: 345-354.
Pomeroy C, Mitchell J, Eckert E, Raymond N, Crosby R, Dalmasso AP: Effect of body weight and calorie restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity. Clin Exp Immunol. 1997, 108: 507-515. 10.1046/j.1365-2249.1997.3921287.x.
Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN: Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res. 1998, 39: 884-891.
Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD: Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res. 2000, 41: 1963-1968.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
Iglesias P, Alvarez FP, Codoceo R, Diez JJ: Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003, 59: 621-629. 10.1046/j.1365-2265.2003.01897.x.
Santini F, Marsilli A, Mammoli C, Valeriano R, Scartabelli G, Pelosini C: Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest. 2004, 27: RC7-
Yaturu S, Prado S, Grimes SR: Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem. 2004, 93: 491-6. 10.1002/jcb.20188.
Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W: Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab. 2003, 88: 2714-2718. 10.1210/jc.2002-021583.
Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O: Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes. 2003, 52: 1182-1186.
Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S: Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003, 52: 239-243.
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL: Plasma adiponectin levels in overweight and obese Asians. Obes Res. 2002, 10: 1104-1110.
Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103: 137-142.
Haque WA, Shimomura I, Matsuzawa Y, Garg A: Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002, 87: 2395-10.1210/jc.87.5.2395.
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001, 86: 3815-3819. 10.1210/jc.86.8.3815.
Yoda M, Nakano Y, Tobe T, Shioda S, Choi-Miura NH, Tomita M: Characterization of mouse GBP28 and its induction by exposure to cold. Int J Obesity Rel Metab Dis. 2001, 25: 75-83. 10.1038/sj.ijo.0801482.
Stefan N, Stumvoll M: Adiponectin – its role in metabolism and beyond. Horm Metab Res. 2002, 34: 469-474. 10.1055/s-2002-34785.
Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001, 288: 1102-1107. 10.1006/bbrc.2001.5904.
Viengchareun S, Zennaro MC, Pascual-Le Tallec L, Lombes M: Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Lett. 2002, 532: 345-350. 10.1016/S0014-5793(02)03697-9.
Cheng SY: Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord. 2000, 1: 9-18. 10.1023/A:1010052101214.
Harvey CB, Williams GR: Mechanism of thyroid hormone action. Thyroid. 2002, 12: 441-446. 10.1089/105072502760143791.
Scantlebury T, Sniderman AD, Cianflone K: Retinoic acid regulation of Acylation Stimulating Protein (ASP) and complement C3 in human adipocytes. Biochem J. 2001, 356: 445-452. 10.1042/0264-6021:3560445.
Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman AD: Fasting acylation stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res. 2004, 45: 124-131. 10.1194/jlr.M300214-JLR200.
Xia Z, Sniderman AD, Cianflone K: Acylation-stimulating Protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem. 2002, 277: 45874-45879. 10.1074/jbc.M207281200.
Murray I, Havel PJ, Sniderman AD, Cianflone K: Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology. 2000, 141: 1041-1049. 10.1210/en.141.3.1041.
Xia Z, Stanhope KL, Digitale E, Simion O-M, Chen LY, Havel PJ: ASP deficiency results in increased energy expenditure in mice. J Biol Chem. 2004, 279: 4051-4057. 10.1074/jbc.M311319200.
Celik I, Akalin S, Erbas T: Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol. 1995, 132: 668-672.
Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol. 2000, 143: 197-202. 10.1530/eje.0.1430197.
Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A: Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003, 285: E527-E533.
Kalant D, Maslowska M, Scantlebury T, Wang H, Cianflone K: Control of lipogenesis in adipose tissue and the role of Acylation Stimulating Protein. Canadian Journal of Diabetes. 2003, 27: 154-171.
Riis AL, Gravholt CH, Djurhuus CB, Norrelung H, Jorgensen JO, Weeke J: Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab. 2002, 87: 4747-4753. 10.1210/jc.2002-020174.
Fryer LG, Holness MJ, Sugden MC: Selective modification of insulin action in adipose tissue by hyperthyroidism. Endocrinology. 1997, 154: 513-522. 10.1677/joe.0.1540513.
Richelsen B, Sorensen NS: Alpha 2- and beta-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism. 1987, 36: 1031-1039. 10.1016/0026-0495(87)90022-9.
Germack R, Starzec A, Perret GY: Regulation of beta 1- and beta 3-adrenergic agonist-stimulated lipolytic response in hyperthyroid and hypothyroid rat white adipocytes. Br J Pharmacol. 2000, 129: 448-456. 10.1038/sj.bjp.0703008.
Wahrenberg H, Engfeldt P, Arner P, Wennlund A, Ostman J: Adrenergic regulation of lipolysis in human adipocytes: findings in hyper- and hypothyroidism. J Clin Endocrinol Metab. 1986, 63: 631-638.
Gong DW, He Y, Karas M, Reitman M: Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem. 1997, 272: 24129-24132. 10.1074/jbc.272.39.24129.
Blennemann B, Moon YK, Freake HC: Tissue-specific regulation of fatty acid synthesis by thyroid hormone. Endocrinology. 1992, 130: 637-643. 10.1210/en.130.2.637.
Kern PA, Ranganathan G, Yukht A, Ong JM, Davis RC: Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region. J Lipid Res. 1996, 37: 2332-2340.
Saffari B, Ong JM, Kern PA: Regulation of adipose tissue lipoprotein lipase gene expression by thyroid hormone in rats. J Lipid Res. 1992, 33: 241-249.